MISO offers to test anticancer drug candidates in combination with FDA-approved radiotherapy. Our drug combination assay is done on a 3D-spheroid model for increased realism and more predictive results.
Investors 2
| Date | Name | Website |
| 04.10.2022 | Front Row ... | frontrow.v... |
| 07.02.2022 | ACET | acet.ca |